ROCKVILLE, Md.--(BUSINESS WIRE)--June 16, 2006--CDEX, Inc. (OTCBB:CEXI.OB - News) announced today that it recorded the highest quarterly revenue in the history of the company in the fiscal second quarter, ending April 30, 2006. Revenue was $351,038 as compared to $23,860 during the second fiscal quarter of 2005. The increase of $327,177 (or 1,371%) resulted from the delivery of ValiMed (TM) medication verification systems to Baxa Corporation. Baxa represents the CDEX ValiMed product line, exclusively in the USA and Canada.
